A detailed history of Td Asset Management Inc transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Td Asset Management Inc holds 312,952 shares of IMCR stock, worth $8.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
312,952
Previous 264,896 18.14%
Holding current value
$8.87 Million
Previous $8.98 Million 8.52%
% of portfolio
0.01%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$30.06 - $41.49 $1.44 Million - $1.99 Million
48,056 Added 18.14%
312,952 $9.74 Million
Q2 2024

Aug 02, 2024

BUY
$33.78 - $63.75 $1.69 Million - $3.18 Million
49,882 Added 23.2%
264,896 $8.98 Million
Q1 2024

May 08, 2024

SELL
$60.14 - $75.36 $7.93 Million - $9.94 Million
-131,916 Reduced 38.02%
215,014 $14 Million
Q4 2023

Feb 12, 2024

BUY
$42.85 - $69.5 $1.93 Million - $3.13 Million
45,010 Added 14.91%
346,930 $23.7 Million
Q3 2023

Oct 27, 2023

BUY
$49.5 - $66.6 $7.83 Million - $10.5 Million
158,086 Added 109.91%
301,920 $15.7 Million
Q2 2023

Aug 09, 2023

BUY
$48.54 - $61.64 $2.31 Million - $2.93 Million
47,581 Added 49.43%
143,834 $8.62 Million
Q1 2023

May 10, 2023

BUY
$46.12 - $65.71 $154,363 - $219,931
3,347 Added 3.6%
96,253 $4.76 Million
Q4 2022

Feb 06, 2023

BUY
$45.51 - $65.08 $568,875 - $813,500
12,500 Added 15.55%
92,906 $5.3 Million
Q3 2022

Nov 07, 2022

BUY
$37.34 - $57.44 $1.98 Million - $3.04 Million
52,900 Added 192.32%
80,406 $3.69 Million
Q1 2021

May 14, 2021

BUY
$36.3 - $56.34 $998,467 - $1.55 Million
27,506 New
27,506 $1.17 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.